Network-Driven Drug Discovery

‍

WEBINAR SUMMARY:

• Jonny Wray is the CTO of e-therapeutics, a drug discovery company specializing in network-driven drug discovery.
• Network-driven drug discovery is an in-silico approach that applies network biology and systems thinking to reduce late-stage clinical failures in drug development.
• The approach focuses on altering phenotypes at the molecular level by manipulating networks through drug targets and transduction mechanisms.
• e-therapeutics gathers data from various sources, including protein interactions, text mining, and cell-specific experiments, to create a comprehensive database of molecular interactions.
• The company utilizes compound databases and analyzes their impact on the network to identify potential drug candidates, validate targets, and drive therapeutic programs.